“A Defining Investment”
Safanad founder and CEO Kamal Bahamdan characterized the transaction as the culmination of a partnership-driven strategy rather than a simple exit.
“HC-One has been a defining investment for Safanad and a clear example of our long-term, partnership-driven approach,” Bahamdan said. Over the past decade, he added, Safanad worked closely with the company’s management to fortify its operational backbone, upgrade systems and elevate care standards for thousands of residents nationwide.
He said the company modernized operations, strengthened governance and laid what he described as a durable foundation for future growth. Bahamdan expressed confidence that HC-One is positioned for its “next chapter” under new ownership, while Safanad continues expanding its global healthcare footprint.
A Decade of Expansion and Modernization
The sale caps a 10-year investment period during which Safanad said it helped propel HC-One’s rise through both organic growth and four strategic bolt-on acquisitions. Like adding extensions to a sprawling estate, each acquisition broadened the platform’s reach and operational scale.
Safanad said it committed substantial capital toward infrastructure improvements, digital transformation and operational modernization. Those investments, according to the firm, enhanced performance metrics, strengthened corporate governance and improved the quality of care delivered across its facilities.
The transaction underscores Safanad’s broader strategy: forging long-term partnerships and channeling capital into social infrastructure assets worldwide — sectors where steady demand meets structural societal shifts.
